Select the financial statements you wish to view below. The reports below may be viewed on either an annual or quarterly basis.
Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Revenue | 209,715 | 255,602 | 255,748 | 217,199 |
Cost of Revenue | 136,802 | 56,900 | 154,301 | 138,229 |
Gross Profit | 72,913 | 198,702 | 101,447 | 78,970 |
Operating Expenses | ||||
Research Development | -- | -- | -- | -- |
Selling General and Administrative | 52,214 | (40,392) | 60,727 | 54,744 |
Non Recurring | -- | -- | -- | -- |
Others | 0 | 185,174 | (1,018) | 0 |
Total Operating Expenses | 52,214 | 144,782 | 59,709 | 54,744 |
Operating Income or Loss | 20,699 | 53,920 | 41,738 | 24,226 |
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | 1,023 | (3,617) | -- | 54 |
Earnings Before Interest And Taxes | -- | 57,537 | 41,738 | 24,172 |
Interest Expense | -- | -- | -- | -- |
Income Before Tax | 12,375 | 29,685 | 33,788 | 17,454 |
Income Tax Expense | 3,436 | 6,860 | 9,138 | 4,769 |
Minority Interest | 5,404 | 5,199 | 4,846 | 7,329 |
Net Income From Continuing Ops | 8,939 | 22,825 | 24,650 | 12,685 |
Non-recurring Events | ||||
Discontinued Operations | -- | -- | -- | -- |
Extraordinary Items | -- | -- | -- | -- |
Effect Of Accounting Changes | -- | -- | -- | -- |
Other Items | (204) | (353) | 55 | 0 |
Net Income | 8,735 | 22,472 | 24,705 | 12,685 |
Preferred Stock And Other Adjustments | -- | -- | -- | -- |
Net Income Applicable To Common Shares | 8,735 | 22,472 | 24,705 | 12,685 |